Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaji Kumar

Showing results (41-50 of 515) with videos related to

Pageof 52
Sort By:
Methods in Molecular Medicine|June 22, 2005
Plasma cell labeling indexPhilip R Greipp, Shaji Kumar
Leukemia & Lymphoma|October 24, 2025
Risk stratification and early intervention in smoldering multiple myelomaManraj Singh Sra, Shaji Kumar
The New England Journal of Medicine|October 1, 2025
Monoclonal Gammopathy of Undetermined SignificanceS Vincent Rajkumar, Shaji Kumar
Mayo Clinic Proceedings|January 15, 2016
Multiple Myeloma: Diagnosis and TreatmentS Vincent Rajkumar, Shaji Kumar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2020
BiTEing the TumorShaji Kumar, S Vincent Rajkumar
Lancet (London, England)|July 30, 2019
Surrogate endpoints in randomised controlled trials: a reality checkShaji Kumar, S Vincent Rajkumar
European Journal of Cancer (Oxford, England : 1990)|June 6, 2006
Thalidomide and lenalidomide in the treatment of multiple myelomaShaji Kumar, S Vincent Rajkumar
Nature Clinical Practice. Oncology|November 3, 2005
Drug insight: thalidomide as a treatment for multiple myelomaShaji Kumar, Kenneth C Anderson
Haematologica|December 10, 2009
The significance of monoclonal gammopathy of undetermined significanceRobert A Kyle, Shaji Kumar
Blood Cancer Journal|August 24, 2020
Immune-based therapies in the management of multiple myelomaSaurabh Zanwar, Bharat Nandakumar, Shaji Kumar
Pageof 52

Showing results (41-50 of 515) with videos related to

Sort By:
Pageof 52
Methods in Molecular Medicine|June 22, 2005
Plasma cell labeling indexPhilip R Greipp, Shaji Kumar
Leukemia & Lymphoma|October 24, 2025
Risk stratification and early intervention in smoldering multiple myelomaManraj Singh Sra, Shaji Kumar
The New England Journal of Medicine|October 1, 2025
Monoclonal Gammopathy of Undetermined SignificanceS Vincent Rajkumar, Shaji Kumar
Mayo Clinic Proceedings|January 15, 2016
Multiple Myeloma: Diagnosis and TreatmentS Vincent Rajkumar, Shaji Kumar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2020
BiTEing the TumorShaji Kumar, S Vincent Rajkumar
Lancet (London, England)|July 30, 2019
Surrogate endpoints in randomised controlled trials: a reality checkShaji Kumar, S Vincent Rajkumar
European Journal of Cancer (Oxford, England : 1990)|June 6, 2006
Thalidomide and lenalidomide in the treatment of multiple myelomaShaji Kumar, S Vincent Rajkumar
Nature Clinical Practice. Oncology|November 3, 2005
Drug insight: thalidomide as a treatment for multiple myelomaShaji Kumar, Kenneth C Anderson
Haematologica|December 10, 2009
The significance of monoclonal gammopathy of undetermined significanceRobert A Kyle, Shaji Kumar
Blood Cancer Journal|August 24, 2020
Immune-based therapies in the management of multiple myelomaSaurabh Zanwar, Bharat Nandakumar, Shaji Kumar
Pageof 52